Improving pathology and laboratory medicine in low-income and middle-income countries: roadmap to solutions
- PMID: 29550027
- DOI: 10.1016/S0140-6736(18)30459-8
Improving pathology and laboratory medicine in low-income and middle-income countries: roadmap to solutions
Abstract
Insufficient awareness of the centrality of pathology and laboratory medicine (PALM) to a functioning health-care system at policy and governmental level, with the resultant inadequate investment, has meant that efforts to enhance PALM in low-income and middle-income countries have been local, fragmented, and mostly unsustainable. Responding to the four major barriers in PALM service delivery that were identified in the first paper of this Series (workforce, infrastructure, education and training, and quality assurance), this second paper identifies potential solutions that can be applied in low-income and middle-income countries (LMICs). Increasing and retaining a quality PALM workforce requires access to mentorship and continuing professional development, task sharing, and the development of short-term visitor programmes. Opportunities to enhance the training of pathologists and allied PALM personnel by increasing and improving education provision must be explored and implemented. PALM infrastructure must be strengthened by addressing supply chain barriers, and ensuring laboratory information systems are in place. New technologies, including telepathology and point-of-care testing, can have a substantial role in PALM service delivery, if used appropriately. We emphasise the crucial importance of maintaining PALM quality and posit that all laboratories in LMICs should participate in quality assurance and accreditation programmes. A potential role for public-private partnerships in filling PALM services gaps should also be investigated. Finally, to deliver these solutions and ensure equitable access to essential services in LMICs, we propose a PALM package focused on these countries, integrated within a nationally tiered laboratory system, as part of an overarching national laboratory strategic plan.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Comment in
-
Pathology and laboratory medicine in partnership with global surgery: working towards universal health coverage.Lancet. 2018 May 12;391(10133):1875-1877. doi: 10.1016/S0140-6736(18)30310-6. Epub 2018 Mar 15. Lancet. 2018. PMID: 29550028 No abstract available.
-
Laboratory medicine in low-income and middle-income countries: progress and challenges.Lancet. 2018 May 12;391(10133):1873-1875. doi: 10.1016/S0140-6736(18)30308-8. Epub 2018 Mar 15. Lancet. 2018. PMID: 29550031 Free PMC article. No abstract available.
-
WHO model list of essential in vitro diagnostics: strengthening diagnostics capacity to transform health care for all.Lancet Glob Health. 2024 Mar;12(3):e364-e365. doi: 10.1016/S2214-109X(23)00568-5. Lancet Glob Health. 2024. PMID: 38365406 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources